How to Start a Regenerative Medicine Practice

Most clinicians who add regenerative medicine to their practice start with a device demonstration and a supplier's protocol. That is the wrong order, and it is why a proportion of them stop within two years.

1. Decide what you are actually offering

Regenerative medicine is not a speciality you bolt on wholesale. Choose the indication set that matches your existing patients: an orthopaedic surgeon and a gynaecologist need entirely different protocols, equipment and consent processes. Narrow beats broad, particularly at the start.

2. Get the science before the equipment

Suppliers train you on their device. Nobody trains you on why one preparation works and another does not, how to appraise a trial, or how to decide when the evidence does not support the treatment at all. That gap is what separates a practice that lasts from one that does not. See the fellowship →

3. Understand your regulatory position first, not last

In India this is not optional and the position tightened in 2026. Know which indications are on the approved list, which interventions require CDSCO or DHR approval, and what your obligations are if you are working outside the approved list — because then you are conducting research, and research has rules. Read the regulation guide →

4. Equipment and consumables

Buy for the indication you chose, not for the whole field. Decide between open and closed processing systems on the basis of sterility assurance and your regulatory position, keep your first-year purchases to what your core protocol actually needs, and defer the rest. Ask every vendor for the specification and the characterisation data, and stay vendor-neutral — the kit should follow the clinical decision, not drive it.

5. Consent and documentation

Your consent form is your primary protection. It must state the evidence status of the intervention in language a patient understands, describe alternatives including doing nothing, and record what was actually discussed. Photograph and document outcomes systematically from your first case — it becomes your audit, your teaching material and eventually your publication.

6. Pricing and honesty in marketing

Price on the outcome and the episode of care, not per syringe. Never guarantee a result — it is both clinically wrong and legally exposed — and keep every public claim within what advertising regulation permits. The commonest source of trouble is historic website copy nobody has revisited; review yours.

7. Build referral relationships, not an advertising budget

Durable practices grow on peer referral and multidisciplinary positioning. Speaking and publishing in the field builds the credibility that advertising cannot buy.

8. Measure and publish

Track outcomes from case one. A clinician with fifty documented cases and one publication occupies a different position from one with a testimonial page.

The mistakes that end practices

• Offering treatments outside the approved indication list
• Promising outcomes the evidence does not support
• Buying equipment before deciding on the indication
• Learning a protocol without understanding the biology beneath it
• Consent forms that do not name the evidence status
• Never auditing your own results